Government has been known to mandate certain life saving vaccines quickly, without years and years of clinical trials hobbled by a burdensome administrative state about as efficient as the U.S. postal service. Cancer patients dealt a death sentence wonder why a vaccine that’s been around for over a decade with a promising cure rate can’t be made widely available right now, before death do they part cancer’s death row.
A cancer research scientist has developed a tumor lysate particle only (TLPO) vaccine that once injected has the ability to detect cancer cells as an infection, allowing the immune system to fight and defeat the cancer itself.
“People used to ask me the question, ‘When will there be a cure for cancer?’ And I’ve been doing this for 60 years and I could never answer that question…..Until recently, until the last three or four or five years.”
Treatment has been available for years for a lucky few:
“His father went through numerous lung surgeries for cancer over a decade ago but was left with no other treatment options. He opted to try Wagner’s cancer vaccine and lived 10 more years before dying from something unrelated to cancer. “You can tell me a lot of things, but you can’t tell me the vaccine doesn’t work.”
Cancer Vaccine Shows Promising Results – Nearing Phase 3 Clinical Trials
Summary
- Typically, cancer cells evade a person’s immune system because it is recognized as that person’s cells
- Many traditional cancer treatments, such as chemotherapy, work by killing off cancer cells but also kill off non-cancerous cells throughout the body
- 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free
- Among the most advanced forms of melanoma, disease-free survival after three years for people with stage III disease was 60% in the vaccine-only group, compared to about 39% in the placebo group
- Disease-free survival for those with stage IV disease was about 68% in the vaccine-only group, and zero in the placebo group
- Phase 2 clinical trials aren’t conclusive
- Phase 3 clinical trial will have to ultimately validate if this cancer vaccine and will take 3 years
- Phase 3 clinical trial is a $100 million project
- Before this vaccine can be more widely available it needs to show success over years in a phase 3 clinical trial and then get final approval by the government
RELATED BLOG POST: Cancer Cure?
